Market Insights Health Hospitals Inpatient Care

Neoplasm Treatment - United Arab Emirates

United Arab Emirates

The Neoplasm Treatment market in the United Arab Emirates is expected to experience significant growth in the coming years.
By 2024, the projected revenue is estimated to reach US$1.09bn.
This growth is predicted to continue with an annual growth rate (CAGR 2024-2029) of 6.59%, resulting in a market volume of US$1.50bn by 2029.
When compared globally, in the United Arab Emirates is anticipated to generate significant revenue.
However, it is worth noting that United States is expected to lead in terms of revenue generation, with a projected revenue of US$90.56bn in 2024.
With the increasing investment in advanced medical technologies and the establishment of specialized cancer treatment centers, the United Arab Emirates is becoming a hub for innovative neoplasm treatment.

Key regions: Europe, Canada, Brazil, United States, United Kingdom

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.